U.S. Stem Cell, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
U.S. Stem Cell, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q4 2022.
  • U.S. Stem Cell, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2022 was 634M shares, a 26% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 634M +131M +26% Dec 31, 2022 10-K 2023-04-14
Q3 2022 632M +171M +37.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 598M +146M +32.4% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 592M +141M +31.4% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 504M +68M +15.6% Dec 31, 2021 10-K 2023-04-14
Q3 2021 461M +31.5M +7.33% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 452M +23.7M +5.55% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 450M +25.5M +6% Mar 31, 2021 10-Q 2021-07-16
Q4 2020 436M +17.8M +4.27% Dec 31, 2020 10-K/A 2022-07-08
Q3 2020 430M +32M +8.04% Sep 30, 2020 10-Q 2021-07-16
Q2 2020 428M +34.3M +8.71% Jun 30, 2020 10-Q 2021-07-16
Q1 2020 425M +35.3M +9.05% Mar 31, 2020 10-Q 2021-07-16
Q4 2019 418M +39.6M +10.5% Dec 31, 2019 10-K 2021-07-16
Q3 2019 398M +29.4M +7.99% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 394M +27.3M +7.45% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 390M +31M +8.63% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 378M +36M +10.5% Dec 31, 2018 10-K 2021-07-16
Q3 2018 368M +29M +8.55% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 366M +29.9M +8.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 359M +31.1M +9.5% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 342M +215M +169% Dec 31, 2017 10-K 2019-03-13
Q3 2017 339M +310M +1061% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 336M +328M +3697% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 328M +325M +11832% Mar 31, 2017 10-Q 2017-05-02
Q4 2016 127M +125M +7248% Dec 31, 2016 10-K/A 2018-04-26
Q3 2016 29.2M +28.3M +3008% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 8.86M -787M -98.9% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 2.75M -668M -99.6% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 1.73M +1.15M Dec 31, 2015 10-K 2017-03-15
Q3 2015 940K -533M -99.8% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 795M +289M +57% Jun 30, 2015 10-Q 2015-08-03
Q1 2015 671M +250M +59.3% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 581K* -379M Dec 31, 2014 10-K 2016-03-08
Q3 2014 534M +214M +67.1% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 507M +279M +123% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 421M +230M +121% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 380M +198M +109% Dec 31, 2013 10-K 2015-03-16
Q3 2013 319M +151M +90.3% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 228M +90.6M +66.1% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 190M +57.6M +43.3% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 182M +86.4M +90.4% Dec 31, 2012 10-K 2014-03-25
Q3 2012 168M +97.4M +138% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 137M +91.5M +201% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 133M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 95.6M +58.1M +155% Dec 31, 2011 10-K 2013-03-29
Q3 2011 70.5M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 45.5M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 37.5M Dec 31, 2010 10-K/A 2013-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.